Literature DB >> 2839409

Close linkage of a highly polymorphic marker (D5S37) to familial adenomatous polyposis (FAP) and confirmation of FAP localization on chromosome 5q21-q22.

P Meera Khan1, C M Tops, M vd Broek, C Breukel, J T Wijnen, M Oldenburg, J vd Bos, I S van Leeuwen-Cornelisse, H F Vasen, G Griffioen.   

Abstract

Fifteen apparently unrelated Dutch families with familial adenomatous polyposis (FAP) also known as familial polyposis coli (FPC; McKusick No. 17510) were screened for linkage with the DNA probe C11p11 localized on chromosome 5q21-22 and previously reported to be closely linked to FAP (Bodmer et al. 1987; Leppert et al. 1987). In our study C11p11 was minimally informative, which is ascribable to its low heterozygosity in the North European populations. Of the above families, 12 were investigated also for linkage with D5S37 (DNA probe Pi227). Data from 11 of them were found to be informative and showed that FAP is closely linked to D5S37 previously localized on chromosome 5q21 (peak lod score 7.85 at a recombination fraction of 0.048 with 95% probability limits 0.005-0.145). Results discussed below indicate for the first time that the most likely location of the FAP gene is in the band 5q22 very close to 5q21, if not in the transitional zone between these two bands. The probe Pi227 recognizes 4 restriction fragment length polymorphism (RFLP) sites, exhibiting a total of 9 alleles with 24 theoretically possible haplotypes in the Dutch population. Therefore, this probe appears to have potential as a generally useful predictive marker for FAP until much closer and similarly useful markers become available.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839409     DOI: 10.1007/BF00280563

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  7 in total

Review 1.  DNA polymorphism and human disease.

Authors:  J F Gusella
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

2.  An anonymous DNA segment (II227) maps to the long arm of human chromosome 5 and identifies a BstXI polymorphism (D5S26).

Authors:  G D Stewart; G A Bruns; J J Wasmuth; D M Kurnit
Journal:  Nucleic Acids Res       Date:  1987-05-11       Impact factor: 16.971

3.  Localization of the gene for familial adenomatous polyposis on chromosome 5.

Authors:  W F Bodmer; C J Bailey; J Bodmer; H J Bussey; A Ellis; P Gorman; F C Lucibello; V A Murday; S H Rider; P Scambler
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

4.  Isolation of probes detecting restriction fragment length polymorphisms from X chromosome-specific libraries: potential use for diagnosis of Duchenne muscular dystrophy.

Authors:  M H Hofker; M C Wapenaar; N Goor; E Bakker; G J van Ommen; P L Pearson
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  Gardner syndrome in a man with an interstitial deletion of 5q.

Authors:  L Herrera; S Kakati; L Gibas; E Pietrzak; A A Sandberg
Journal:  Am J Med Genet       Date:  1986-11

6.  The gene for familial polyposis coli maps to the long arm of chromosome 5.

Authors:  M Leppert; M Dobbs; P Scambler; P O'Connell; Y Nakamura; D Stauffer; S Woodward; R Burt; J Hughes; E Gardner
Journal:  Science       Date:  1987-12-04       Impact factor: 47.728

7.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

  7 in total
  17 in total

1.  Predictive diagnosis of familial adenomatous polyposis with linked DNA markers: population based study.

Authors:  F MacDonald; D G Morton; P M Rindl; J Haydon; R Cullen; J Gibson; J P Neoptolemos; M R Keighley; C M McKeown; M Hultén
Journal:  BMJ       Date:  1992-04-04

2.  Risk estimation in familial adenomatous polyposis using DNA probes linked to the familial adenomatous polyposis gene.

Authors:  D J Koorey; G W McCaughan; R J Trent; N D Gallagher
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

Review 3.  Genetics of colon cancer.

Authors:  D J Ahnen
Journal:  West J Med       Date:  1991-06

4.  Probe KK5.33 (D5S85) improves indirect genotype analysis in familial adenomatous polyposis.

Authors:  W Friedl; A Krömer; P Propping
Journal:  Hum Genet       Date:  1991-02       Impact factor: 4.132

5.  Linkage studies in Italian families with familial adenomatous polyposis.

Authors:  C Mareni; A Stella; P Origone; F Susca; M P Montera; A Lonoce; M Ponz de Leon; R Sassatelli; M Gentile; A Straface
Journal:  Hum Genet       Date:  1993-01       Impact factor: 4.132

6.  Loss of normal allele of the APC gene in an adrenocortical carcinoma from a patient with familial adenomatous polyposis.

Authors:  M Seki; K Tanaka; R Kikuchi-Yanoshita; M Konishi; H Fukunari; T Iwama; M Miyaki
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

7.  Loss of constitutional heterozygosity in human astrocytomas.

Authors:  E Van de Kelft; K De Boulle; P Willems; J J Martin; P Selosse; B Van der Auwera
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

8.  Linkage analysis in adenomatous polyposis coli: the use of four closely linked DNA probes in 20 UK families.

Authors:  M B Cachon-Gonzalez; J D Delhanty; J Burn; K Tsioupra; M B Davis; J Attwood; P Chapman
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

9.  Value of combined phenotypic markers in identifying inheritance of familial adenomatous polyposis.

Authors:  F M Giardiello; G J Offerhaus; E I Traboulsi; J C Graybeal; I H Maumenee; A J Krush; L S Levin; S V Booker; S R Hamilton
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

10.  The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations.

Authors:  J Burn; P Chapman; J Delhanty; C Wood; F Lalloo; M B Cachon-Gonzalez; K Tsioupra; W Church; M Rhodes; A Gunn
Journal:  J Med Genet       Date:  1991-05       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.